{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:57Z","timestamp":1786993137661,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jocn.2025.111189","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T13:34:54Z","timestamp":1742477694000},"page":"111189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of tranexamic acid on rebleeding, mortality, and hydrocephalus in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"135","author":[{"given":"Mohammed Maan","family":"Al-Salihi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Abd","family":"Elazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Sabah","family":"Al-Jebur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan I.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocn.2025.111189_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBC.0000000000000789","article-title":"What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies","volume":"30","author":"Picetti","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jocn.2025.111189_b0010","article-title":"Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Shi","year":"2021","journal-title":"Front Surg"},{"issue":"6","key":"10.1016\/j.jocn.2025.111189_b0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ana.410030607","article-title":"Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial","volume":"3","author":"Chandra","year":"1978","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2025.111189_b0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.STR.10.5.519","article-title":"Tranexamic acid in subarachnoid haemorrhage. A double-blind study","volume":"10","author":"Kaste","year":"1979","journal-title":"Stroke"},{"issue":"6118","key":"10.1016\/j.jocn.2025.111189_b0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/bmj.1.6118.945","article-title":"Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?","volume":"1","author":"Maurice-Williams","year":"1978","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.jocn.2025.111189_b0030","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.jocn.2025.111189_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59111908","article-title":"Neuroimaging modalities used for ischemic stroke diagnosis and monitoring","volume":"59","author":"Nukovic","year":"2023","journal-title":"Medicina"},{"issue":"10269","key":"10.1016\/j.jocn.2025.111189_b0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","article-title":"Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial","volume":"397","author":"Post","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2025.111189_b0045","doi-asserted-by":"crossref","unstructured":"Weiland J, Beez A, Westermaier T, Kunze E, Sir\u00e9n AL, Lilla N. Neuroprotective strategies in aneurysmal subarachnoid hemorrhage (aSAH). Int J Mol Sci. May 21 2021;22(11)doi:10.3390\/ijms22115442.","DOI":"10.3390\/ijms22115442"},{"key":"10.1016\/j.jocn.2025.111189_b0050","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","volume":"11(11):Cd001245","author":"Germans","year":"2022","journal-title":"Cochrane Database Syst Rev Nov 9"},{"issue":"7","key":"10.1016\/j.jocn.2025.111189_b0055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/00207454.2022.2148957","article-title":"Tranexamic acid for patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of 2991 patients","volume":"134","author":"Ghaith","year":"2024","journal-title":"Int J Neurosci"},{"issue":"3","key":"10.1016\/j.jocn.2025.111189_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282726","article-title":"Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis","volume":"18","author":"Xiong","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jocn.2025.111189_b0065","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jocn.2025.111189_b0070","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ Mar 29"},{"issue":"9","key":"10.1016\/j.jocn.2025.111189_b0075","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.STR.0000027437.22450.BD","article-title":"Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale","volume":"33","author":"Wilson","year":"2002","journal-title":"Stroke"},{"issue":"7905","key":"10.1016\/j.jocn.2025.111189_b0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","article-title":"Assessment of outcome after severe brain damage","volume":"1","author":"Jennett","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2025.111189_b0085","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ Aug 28"},{"key":"10.1016\/j.jocn.2025.111189_b0090","unstructured":"Review Manager (RevMan) [Computer program]. The Cochrane Collaboration; 2020. https:\/\/revman.cochrane.org\/."},{"key":"10.1016\/j.jocn.2025.111189_b0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.33.Suppl_14.68","article-title":"Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage","volume":"14","author":"Fodstad","year":"1980","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"issue":"2","key":"10.1016\/j.jocn.2025.111189_b0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/00006123-198102000-00004","article-title":"Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial","volume":"8","author":"Fodstad","year":"1981","journal-title":"Neurosurgery"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2025.111189_b0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01400969","article-title":"Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA)","volume":"56","author":"Fodstad","year":"1981","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"10.1016\/j.jocn.2025.111189_b0110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study","volume":"97","author":"Hillman","year":"2002","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2025.111189_b0115","first-page":"77","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial","volume":"54","author":"Roos","year":"2000","journal-title":"STAR Study Group Neurology"},{"issue":"12","key":"10.1016\/j.jocn.2025.111189_b0120","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209169","article-title":"Ultra-early and short-term tranexamic acid treatment in patients with good- and poor-grade aneurysmal subarachnoid hemorrhage","volume":"102","author":"Tjerkstra","year":"2024","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2025.111189_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01402177","article-title":"Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study","volume":"102","author":"Tsementzis","year":"1990","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"10.1016\/j.jocn.2025.111189_b0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410020311","article-title":"Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial","volume":"2","author":"van Rossum","year":"1977","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.jocn.2025.111189_b0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM198408163110703","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage","volume":"311","author":"Vermeulen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2025.111189_b0140","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ajem.2021.09.051","article-title":"Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials","volume":"50","author":"Liu","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jocn.2025.111189_b0145","article-title":"Safety and efficacy of tranexamic acid in aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials","volume":"12","author":"Ren","year":"2021","journal-title":"Front Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825001614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825001614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T14:41:58Z","timestamp":1755096118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"alternative-id":["S0967586825001614"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111189","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of tranexamic acid on rebleeding, mortality, and hydrocephalus in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111189"}}